DERM logo

Journey Medical (DERM) Cash From Financing

Annual CFF

-$4.80 M
-$21.26 M-129.19%

31 December 2023

DERM Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

-$294.00 K
-$5.33 M-105.84%

30 September 2024

DERM Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

$25.58 M
+$10.68 M+71.70%

30 September 2024

DERM TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

DERM Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-129.2%+97.3%+210.9%
3 y3 years-886.5%-102.6%+20.6%
5 y5 years-113.6%--

DERM Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-109.1%at low-100.9%+97.8%-53.5%+210.9%
5 y5 years-109.1%at low-100.9%+97.8%-53.5%+210.9%
alltimeall time-101.0%at low-100.9%+97.8%-53.5%+210.9%

Journey Medical Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$294.00 K(-105.8%)
$25.58 M(+71.7%)
June 2024
-
$5.03 M(+207.3%)
$14.90 M(-562.9%)
Mar 2024
-
$1.64 M(-91.5%)
-$3.22 M(-33.0%)
Dec 2023
-$4.80 M(-129.2%)
$19.21 M(-275.0%)
-$4.80 M(-79.2%)
Sept 2023
-
-$10.98 M(-16.1%)
-$23.07 M(+186.3%)
June 2023
-
-$13.09 M(<-9900.0%)
-$8.06 M(-256.7%)
Mar 2023
-
$52.00 K(-94.5%)
$5.14 M(-68.8%)
Dec 2022
$16.46 M(-69.0%)
$948.00 K(-76.5%)
$16.46 M(-65.2%)
Sept 2022
-
$4.03 M(+3531.5%)
$47.31 M(-13.2%)
June 2022
-
$111.00 K(-99.0%)
$54.49 M(-0.9%)
Mar 2022
-
$11.37 M(-64.3%)
$54.99 M(+3.7%)
Dec 2021
$53.02 M
$31.80 M(+183.6%)
$53.02 M(+149.9%)
DateAnnualQuarterlyTTM
Sept 2021
-
$11.21 M(+1720.0%)
$21.22 M(+112.0%)
June 2021
-
$616.00 K(-93.4%)
$10.01 M(+6.6%)
Mar 2021
-
$9.39 M
$9.39 M
Dec 2020
-$487.00 K(-86.3%)
-
-
Dec 2019
-$3.55 M(-110.0%)
-
-
Dec 2018
$35.38 M(-92.4%)
-
-
Dec 2017
$462.52 M(+232.9%)
-
-
Dec 2016
$138.95 M(+35.0%)
-
-
Dec 2015
$102.93 M(-40.9%)
-
-
Dec 2014
$174.10 M(+557.5%)
-
-
Dec 2013
$26.48 M(+119.5%)
-
-
Dec 2012
$12.06 M
-
-

FAQ

  • What is Journey Medical annual cash flow from financing activities?
  • What is the all time high annual CFF for Journey Medical?
  • What is Journey Medical annual CFF year-on-year change?
  • What is Journey Medical quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Journey Medical?
  • What is Journey Medical quarterly CFF year-on-year change?
  • What is Journey Medical TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Journey Medical?
  • What is Journey Medical TTM CFF year-on-year change?

What is Journey Medical annual cash flow from financing activities?

The current annual CFF of DERM is -$4.80 M

What is the all time high annual CFF for Journey Medical?

Journey Medical all-time high annual cash flow from financing activities is $462.52 M

What is Journey Medical annual CFF year-on-year change?

Over the past year, DERM annual cash flow from financing activities has changed by -$21.26 M (-129.19%)

What is Journey Medical quarterly cash flow from financing activities?

The current quarterly CFF of DERM is -$294.00 K

What is the all time high quarterly CFF for Journey Medical?

Journey Medical all-time high quarterly cash flow from financing activities is $31.80 M

What is Journey Medical quarterly CFF year-on-year change?

Over the past year, DERM quarterly cash flow from financing activities has changed by +$10.68 M (+97.32%)

What is Journey Medical TTM cash flow from financing activities?

The current TTM CFF of DERM is $25.58 M

What is the all time high TTM CFF for Journey Medical?

Journey Medical all-time high TTM cash flow from financing activities is $54.99 M

What is Journey Medical TTM CFF year-on-year change?

Over the past year, DERM TTM cash flow from financing activities has changed by +$48.65 M (+210.92%)